Home
About
Why D4DPR?
Strategic Vision
Platform of Regulations
Leadership
D4DPR Experts
D4DPR Updates
Advocacy
Media
Expert Testimony
Coalition Partners
Education
Cannabis Curriculums
Regulation & Public Health
Harms of Prohibition
Myths, Risks & Uncertainties
Resources
Ask a Question
Regulation
Universal Cannabis Symbol
JOIN
DONATE
Home
Opposing the Colorado Board of Health Proposed Rules for Allowing Greater than 0.3% THC Hemp Products
Opposing the Colorado Board of Health Proposed Rules for Allowing Greater than 0.3% THC Hemp Products
Bryon Adinoff, MD
Expert Testimony
|
November 16, 2023
|
Adult Use (cannabis)
Download PDF
</div><p></p></div><div class="socialshare blog"><div class="text-block-7"><strong>Share: </strong></div><div class="html-embed-7 w-embed"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A//dfcr.org/post/opposing-the-colorado-board-of-health-proposed-rules-for-allowing-greater-than-0-3-thc-hemp-products" target="_blank" class="share-icon-wrap w-inline-block"><img loading="lazy" width="30" src="https://cdn.prod.website-files.com/6140f19dc034b9b282445f9c/6169a5996d25fba25b1aa18a_facebook.png" alt="" class="social-media-icons"></a></div><div class="html-embed-7 w-embed"><a href="https://twitter.com/intent/tweet?text=https%3A//dfcr.org/post/opposing-the-colorado-board-of-health-proposed-rules-for-allowing-greater-than-0-3-thc-hemp-products" target="_blank" class="share-icon-wrap w-inline-block"><img loading="lazy" width="30" src="https://cdn.prod.website-files.com/6140f19dc034b9b282445f9c/6169a5997f7803a3b9c69bdd_twitter.png" alt="" class="social-media-icons"></a></div><div class="html-embed-7 w-embed"><a class="w-inline-block social-share-btn social-media-icons email" href="mailto:?subject=&body=:%20" target="_blank" title="Email" onclick="window.open('mailto:?subject=' + encodeURIComponent(document.title) + '&body=' + encodeURIComponent('https://dfcr.org/post/opposing-the-colorado-board-of-health-proposed-rules-for-allowing-greater-than-0-3-thc-hemp-products')); return false;"><img loading="lazy" width="30" src="https://cdn.prod.website-files.com/6140f19dc034b9b282445f9c/6194228b96c3d141b17766c4_email-svgrepo-com.svg" alt="" class="social-media-icons"></a></div></div><div class="divider"></div></div><div><h2>About the Author</h2><div class="w-row"><div class="w-col w-col-1"><img alt="Bryon Adinoff, MD" loading="lazy" width="140" src="https://cdn.prod.website-files.com/6140f19ec034b96f37445fa8/64dce1c9f89067d165c59d4d_BA%20newsletter%20headshot.png" class="image-6"/></div><div class="w-col w-col-11"><h3>Bryon Adinoff, MD</h3><div class="w-richtext"><p><a href="http://adinoffaddictionpsychiatry.com/" target="_blank"><strong>Bryon Adinoff, MD</strong></a><strong> </strong>is an addiction psychiatrist, neuroscientist, academician, and advocate. He was appointed <a href="https://som.ucdenver.edu/Profiles/Faculty/Profile/27480" target="_blank">Clinical Professor</a> at the University of Colorado School of Medicine following his retirement as Distinguished Professor of Alcohol and Drug Abuse Research in the Department of Psychiatry at the University of Texas Southwestern Medical Center and as a psychiatrist for 30 years with the Department of Veterans Affairs. He has published over <a href="https://pubmed.ncbi.nlm.nih.gov/?term=adinoff+b&&sort=date" target="_blank">200 papers</a> and book chapters on the neurobiology and treatment of addiction and is Editor-in-Chief of <a href="https://www.tandfonline.com/toc/iada20/current" target="_blank">The American Journal of Drug and Alcohol Abuse</a>. In his semi-retired status, he has evolved from focusing on the consequences of substance use itself to the consequences of drug prohibition. His commitment to the goals of D4DPR arises from his desire to ensure that the devastating effects of the global drug war are replaced by a science-based, compassionate, and just system that protects both the individual and society.<br/></p></div></div></div></div></div></div><div class="footer-section"><div class="content-section footer no-padding"><div class="container-wrapper-second footer"><div class="footer-block"><img src="https://cdn.prod.website-files.com/6140f19dc034b9b282445f9c/65170f78c8bbb4e95b23593d_D4DPR%20Horizonal%20Light%20Bkgrd.png" loading="lazy" width="286" sizes="(max-width: 479px) 83vw, (max-width: 767px) 41vw, (max-width: 991px) 29vw, (max-width: 1279px) 18vw, (max-width: 1919px) 222.2265625px, 286px" alt="D4DPR logo" srcset="https://cdn.prod.website-files.com/6140f19dc034b9b282445f9c/65170f78c8bbb4e95b23593d_D4DPR%20Horizonal%20Light%20Bkgrd-p-500.png 500w, https://cdn.prod.website-files.com/6140f19dc034b9b282445f9c/65170f78c8bbb4e95b23593d_D4DPR%20Horizonal%20Light%20Bkgrd-p-800.png 800w, https://cdn.prod.website-files.com/6140f19dc034b9b282445f9c/65170f78c8bbb4e95b23593d_D4DPR%20Horizonal%20Light%20Bkgrd-p-1080.png 1080w, https://cdn.prod.website-files.com/6140f19dc034b9b282445f9c/65170f78c8bbb4e95b23593d_D4DPR%20Horizonal%20Light%20Bkgrd.png 1300w"/><div class="w-embed"><style> .image-container { text-align: center; } </style> <div class="image-container"> <a href="https://www.guidestar.org/profile/shared/ac11f4b2-d8c8-45e0-8006-58a23796b851" target="_blank"> <img src="https://widgets.guidestar.org/TransparencySeal/9511393" width="100" alt="Guidestar Transparency Seal"> </a> </div></div></div><div class="footer-block top"><h4 class="blog-tittle dark footer">Follow</h4><div class="div-block-25 w-clearfix"><a href="https://www.facebook.com/D4DPRorg/" Title="facebook" target="_blank" class="top-social-block second-version w-inline-block w-clearfix"><img src="https://cdn.prod.website-files.com/6140f19dc034b9b282445f9c/6169a5996d25fba25b1aa18a_facebook.png" width="54" alt="Facebook" class="top-nav-icon"/></a><a href="https://twitter.com/d4dprorg" Title="Twitter" target="_blank" class="top-social-block second-version w-inline-block w-clearfix"><img src="https://cdn.prod.website-files.com/6140f19dc034b9b282445f9c/6169a5997f7803a3b9c69bdd_twitter.png" width="49" alt="Twitter" class="top-nav-icon"/></a><a href="https://www.linkedin.com/company/d4dprorg/" Title="LinkedIn" target="_blank" class="top-social-block second-version w-inline-block w-clearfix"><img src="https://cdn.prod.website-files.com/6140f19dc034b9b282445f9c/6169a59a8bfa9732bf790b6e_linkedin.png" width="40" alt="LinkedIn" class="top-nav-icon"/></a><a href="https://www.instagram.com/d4dprorg/" Title="Instagram" target="_blank" class="top-social-block second-version w-inline-block w-clearfix"><img src="https://cdn.prod.website-files.com/6140f19dc034b9b282445f9c/6169a599335ab4511c5e6dd0_insta.png" width="53" alt="Instagram" class="top-nav-icon"/></a><a href="https://www.youtube.com/channel/UC7GLBo2PRDXuL8dzdQC2A3Q" Title="YouTube" target="_blank" class="top-social-block second-version w-inline-block w-clearfix"><img src="https://cdn.prod.website-files.com/6140f19dc034b9b282445f9c/6169a708d0c8a4bd4cf361c6_youtube-svgrepo-com%20(1).svg" width="56" alt="YouTube" class="top-nav-icon"/></a></div></div><div class="footer-block contact"><h4 class="blog-tittle dark footer">Contact Us</h4><p><a href="mailto:info@d4dpr.org">info@d4dpr.org</a></p><p>Phone: (202) 930-0097</p><p>Doctors for Drug Policy Reform<br/>712 H Street NE, Suite 1290<br/>Washington, DC 20002</p></div><div class="footer-block third"><h4 class="blog-tittle dark footer">D4DPR News & Events</h4><a href="https://d4dpr.org/updates/media" class="link-block w-inline-block"><div class="text-block-4">Media</div></a><a href="/expert-testimony" class="link-block w-inline-block"><div class="text-block-4">Expert Testimony</div></a><a href="https://d4dpr.org/updates/education" class="link-block w-inline-block"><div class="text-block-4">Education</div></a><a href="https://d4dpr.org/updates/dfcr" class="link-block w-inline-block"><div class="text-block-4">D4DPR Updates</div></a></div><div class="footer-block fourth"><h4 class="blog-tittle dark footer">Sign Up for Our Newsletter!</h4><div class="html-embed-4 w-embed w-iframe"><iframe src="https://d4dpr.dm.networkforgood.com/forms/102955?iframe=1" width="100%" height="380px" frameborder="0">
©2024 Doctors for Cannabis Regulation, LLC DBA Doctors for Drug Policy Reform. All rights reserved.
